Dr. Matthew Frank, PhD, MD
Claim this profileStanford Cancer Center
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
8 reported clinical trials
14 drugs studied
Area of expertise
1Lymphoma
Philadelphia Chromosome positive
CD22 positive
CD22 negative
2Non-Hodgkin's Lymphoma
Philadelphia Chromosome positive
CD22 positive
CD22 negative
Affiliated Hospitals
Clinical Trials Matthew Frank, PhD, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
CAR T-Cell Therapy
for Leukemia
This trial is testing a treatment that uses special immune cells from a donor, modified to target and kill cancer cells, in adults with a specific type of blood cancer. These cells act like guided missiles, finding and destroying cancer cells by recognizing specific markers.
Recruiting1 award Phase 1
More about Matthew Frank, PhD, MD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Matthew Frank, PhD, MD has experience with
- Cyclophosphamide
- B7-H3CART
- CRG-022
- Axicabtagene Ciloleucel
- Neuropsychological Testing
- CD22 CAR
Breakdown of trials Matthew Frank, PhD, MD has run
Lymphoma
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Frank, PhD, MD specialize in?
Matthew Frank, PhD, MD focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Philadelphia Chromosome positive patients, or patients who are CD22 positive.
Is Matthew Frank, PhD, MD currently recruiting for clinical trials?
Yes, Matthew Frank, PhD, MD is currently recruiting for 5 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Matthew Frank, PhD, MD has studied deeply?
Yes, Matthew Frank, PhD, MD has studied treatments such as Cyclophosphamide, B7-H3CART, CRG-022.
What is the best way to schedule an appointment with Matthew Frank, PhD, MD?
Apply for one of the trials that Matthew Frank, PhD, MD is conducting.
What is the office address of Matthew Frank, PhD, MD?
The office of Matthew Frank, PhD, MD is located at: Stanford Cancer Center, San Francisco, California 94305 United States. This is the address for their practice at the Stanford Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.